Overexpression of TNFRSF11B obviously correlated with late-stage lymph node metastasis and worse survival outcomes (p = 0.010, p = 0.014, and p = 0.0061, respectively) (Figures 2F–H). Here, TNFRSF11B is linked to metastatic malignant neoplasm in the lymph nodes.